Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Atrial fibrillation in KCNE-null mice
Atrial proarrhythmia due to increased inward rectifier current (I-K1) arising from KCNJ2 mutation - A simulation study
Atrial fibrillation in the long QT syndrome
Atrial Arrhythmias in Long-QT Syndrome under Daily Life Conditions: A Nested Case Control Study
Atrial Fibrillation and Stroke Management: Present and Future
Atrial fibrillation: from physiopathology to therapy
Atrial Septal Defect Closure in the Elderly Is Associated With Excellent Quality of Life, Functional Improvement, and Ventricular Remodelling
Atrial fibrillation: How to slow the pace?
Atrial septal pacing for the termination of atrial fibrillation: study in a biophysical model of human atria
Atrial protective effects of n-3 polyunsaturated fatty acids: A long-term study in ovine chronic heart failure
Atrial Fibrillation: Where is the Border Between Pure Antiarrhythmic and Non-Antiarrhythmic Medicines?
Atrial Pacing Site and Atrioventricular Conduction in Patients Paced for Sinus Node Disease
Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome
Atrial cardiomyocyte calcium signalling
Atrial fibrillation: Molecular biology has yet to impact management
Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment
Atrioventricular Nodal Reentrant Tachycardia in Two Siblings with Wolfram syndrome
Atrial fibrillation and congestive heart failure: Risk factors, mechanisms, and treatment
Atrial fibrillation in the elderly
Atrial fibrillation: A historical perspective
Atrial fibrillation as an uncommon presentation in a large pleomorphic xanthoastrocytoma
Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk
Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode
Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose
Atrial natriuretic peptides and urodilatin modulate proximal tubule Na+-ATPase activity through activation of the NPR-A/cGMP/PKG pathway
Atrial defibrillation threshold as a novel predictor of clinical outcome of catheter ablation for persistent atrial fibrillation
Atrial extracellular matrix remodelling in patients with atrial fibrillation
Atrial fibrillation in clinical practice: More answers are required, but do we interpret properly the current evidence? Reply
Atrial Natriuretic Peptide Promotes Pancreatic Islet beta-Cell Growth and Akt/Foxo1a/Cyclin D2 Signaling
Atrial natriuretic peptide and related peptides
Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure
Atrial Fibrillation Associated With Epileptic Seizures
Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)
Atrial Natriuretic Peptide: A Magic Bullet for Cancer Therapy Targeting Wnt Signaling and Cellular pH Regulators
Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods
Atrial fibrillation classification based on the spectrum pattern: Is high frequency the target?
Atrial Repolarization Alternans as a Path to Atrial Fibrillation
Atrial fibrillation and congestive heart failure
Atrial fibrillation and atherothrombosis: The importance of anticoagulation
Atrial fibrillation and atherothrombosis: The importance of anticoagulation Response
Atrial fibrillation and coronary artery disease: Resembling twins?
Atrial Fibrillation and Incident Myocardial Infarction in the Elderly
Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation Implications for the Antiarrhythmic Effect of Statins
Atrial natriuretic peptide effects on intracellular pH changes and ROS production in HEPG2 cells: Role of p38 MAPK and phospholipase D
Atrial natriuretic peptide negatively regulates follicle-stimulating hormone-induced porcine oocyte maturation and cumulus expansion via cGMP-dependent protein kinase pathway
Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention
Atrial fibrillation: epidemiology, prognosis and therapy
Atrial fibrillation in an acute stroke unit
Atrial fibrillation, comorbidities and new anticoagulants
Atrial fibrillation: relieving symptoms and managing risk
Atrial fibrillation in clinical practice: More answers are required
Atrioventricular Node Ablation in Langendorff-Perfused Porcine Hearts Using Carbon Ion Particle Therapy Methods and an In Vivo Feasibility Investigation for Catheter-Free Ablation of Cardiac Arrhythmias
Atrial fibrillation in heart failure: catheter and surgical interventional therapies
Atrial fibrillation ablation using open-irrigated tip radiofrequency: Experience with intraprocedural activated clotting times <= 210 seconds
Atrial fibrillation ablation: Limitations of pulmonary vein ablation catheter technology response
Atrial Septal Angulation Varies Widely in Patients Undergoing Pulmonary Vein Isolation
Atrial Fibrillation Ablation: "Perpetual Motion" of Open Irrigated Tip Catheters at 50 W Is Safe and Improves Outcomes
Atrial fibrillation ablation: contemporary practice and future potential
Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up
Atrial fibrillation: New drugs, devices, and procedures
Atrial Fibrillation and Hypertension: Do New Anticoagulants Change the Matter?
Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST) A 2-Center Randomized Clinical Trial
Atrial fibrillation in elderly. That long way...
Atrial fibrillation (Part 2)
Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients
Atrial Fibrillation in the Athlete
Atrial Fibrillation and Atrial Flutter: Nonpharmacologic Therapy
Atrial fibrillation and atrial flutter in athletes
Atrial fibrillation: is there evidence to support an early ablation strategy?
Atrial Fibrillation, Stroke, and Mortality Rates After Transcatheter Aortic Valve Implantation
Atrial Fibrillation in Endurance Athletes
Atrial Fibrillation: Its Prevalence and Risk Factor Profile in the German General Population
Atrial fibrillation and the use of oral bisphosphonates
Atrial Fibrillation and Stroke Associated With Intravenous Bisphosphonate Therapy in Older Patients With Cancer
Atrial fibrillation and anaesthesia-intensive care: an update
Atrial Fibrillation: Who should be anticoagulated?
Atrial fibrillation: drug, interventional or surgical treatment? For drug treatment
Atrial Fibrillation and Renal Function How High Is the Price of Anticoagulation?
Atrial Fibrillation: How effective and safe are the direct oral Anticoagulants for Prevention of Strokes?
Atrial Fibrillation in Long Term Care
Atrial Fibrillation in Ambulatory Consultant Cardiology Clinics
Atrial Fibrillation Following Intravenous Zolendronic Acid for Osteoporosis
Atrial electromechanical coupling interval and P-wave dispersion in healthy elderly